IGC Pharma Inc
NYSE American:IGC

  • LAST PRICE
    0.4272
  • TODAY'S CHANGE (%)
    -0.0042 (-0.9736%)
  • Bid / Lots
    0.4220/ 5
  • Ask / Lots
    0.4271/ 1
  • Open / Previous Close
    0.4156 / 0.4314
  • Day Range
    0.4100
    0.4366
  • 52 Week Range
    0.2501
    0.9099
  • Volume
    117,727

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Yesterday

  • Jun 24, 2024

      Show headlines and story abstract

    • 7:30PM ET on Monday Jun 24, 2024 by Business Wire
      Companies Mentioned: IGC

      IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American: IGC), a clinical-stage pharmaceutical company, has announced its financial results for the fiscal year ended March 31, 2024 ("Fiscal 2024").

      Full Fiscal Year Highlights

    • 7:30PM ET on Monday Jun 24, 2024 by Dow Jones
      Companies Mentioned: IGC
      Claims and advances 688 1,003 Operating lease asset 198 326 --------- --------- Total non-current assets 6,197 10,712 --------- --------- Total assets 9,902 17,178 --------- --------- LIABILITIES AND STOCKHOLDERS' EQUITY -------------------------------------------- Current liabilities: Accounts payable 773 530 Accrued liabilities and others 1,567 1,368 --------- --------- Total current liabilities 2,340 1,898 --------- --------- Non-current liabilities: Long-term loans 137 141 Other liabilities 20 21 Operating lease liability 84 207 --------- --------- Total non-current liabilities 241 369 --------- --------- Total liabilities 2,581 2,267 --------- --------- Commitments and Contingencies -- See Note 12 Stockholders' equity: Preferred stock, $0.0001 par value: authorized 1,000,000 shares, no shares issued or outstanding as of March 31, 2024, or March 31, 2023. Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 66,691,195 and 53,077,436 shares issued and outstanding as of March 31, 2024, and March 31, 2023, respectively. 124,409 118,965 Accumulated other comprehensive loss (3,423) (3,389) Accumulated deficit (113,665) (100,665) --------- --------- Total stockholders' equity 7,321 14,911 --------- --------- Total liabilities and stockholders' equity 9,902 17,178 ========= =========

    • 7:30PM ET on Monday Jun 24, 2024 by Dow Jones
      Companies Mentioned: IGC
      Operating lease asset 198 326 --------- --------- Total non-current assets 6,197 10,712 --------- --------- Total assets 9,902 17,178 --------- --------- LIABILITIES AND STOCKHOLDERS' EQUITY -------------------------------------------- Current liabilities: Accounts payable 773 530 Accrued liabilities and others 1,567 1,368 --------- --------- Total current liabilities 2,340 1,898 --------- --------- Non-current liabilities: Long-term loans 137 141 Other liabilities 20 21 Operating lease liability 84 207 --------- --------- Total non-current liabilities 241 369 --------- --------- Total liabilities 2,581 2,267 --------- --------- Commitments and Contingencies -- See Note 12 Stockholders' equity: Preferred stock, $0.0001 par value: authorized 1,000,000 shares, no shares issued or outstanding as of March 31, 2024, or March 31, 2023. Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 66,691,195 and 53,077,436 shares issued and outstanding as of March 31, 2024, and March 31, 2023, respectively. 124,409 118,965 Accumulated other comprehensive loss (3,423) (3,389) Accumulated deficit (113,665) (100,665) --------- --------- Total stockholders' equity 7,321 14,911 --------- --------- Total liabilities and stockholders' equity 9,902 17,178 ========= =========

Peers Headlines